Insiders · Profile

Arkowitz David

Director at iBio · Chief Financial Officer at Seres Therapeutics. Filing since 30 Oct 2023. CIK 0001296999

Company
Date
Role
Action
Shares
Amount
Of holding
10 Jan 2025
Director
Bought
18,382
$50.00K
opened
16 Feb 2024
Chief Financial Officer
Sold on a plan
3,939
$4.25K
2.1%
30 Oct 2023
Chief Financial Officer
Sold on a plan
4,066
$5.49K
2.3%
3 decisions on file.